Filing Details
- Accession Number:
- 0001140361-11-045494
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-09-12 17:38:58
- Reporting Period:
- 2011-09-08
- Filing Date:
- 2011-09-12
- Accepted Time:
- 2011-09-12 16:38:58
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1228627 | Rexahn Pharmaceuticals Inc. | RNN | Pharmaceutical Preparations (2834) | 113516358 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1434099 | C. Peter Brandt | C/O Rexahn Pharmaceuticals, Inc. 15245 Shady Grove Road, Suite 455 Rockville MD 20850 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2011-09-08 | 588 | $1.13 | 25,588 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2011-09-08 | 7,200 | $1.12 | 32,788 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2011-09-08 | 13,800 | $1.10 | 46,588 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2011-09-08 | 5,912 | $1.09 | 52,500 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2011-09-08 | 2,500 | $1.10 | 55,000 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2011-09-08 | 15,000 | $1.08 | 70,000 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2011-09-09 | 6,600 | $1.21 | 76,600 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2011-09-09 | 55,100 | $1.22 | 131,700 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2011-09-09 | 13,300 | $1.22 | 145,000 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2011-09-09 | 5,000 | $1.23 | 150,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Reported Derivative Holdings
| Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Options (right-to-buy) | $1.25 | 2021-06-06 | 20,000 | 20,000 | Direct | |
| Common Stock | Stock Options (right-to-buy) | $1.19 | 2020-09-17 | 20,000 | 20,000 | Direct |
| Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|
| 2021-06-06 | 20,000 | 20,000 | Direct |
| 2020-09-17 | 20,000 | 20,000 | Direct |
Footnotes
- These options vest and become exercisable in full on June 6, 2012.
- These options vest and become exercisable in full on September 17, 2011.
Billionaire Hedge Funds
